|
Volumn 3, Issue 2, 2002, Pages 72-76
|
Lifestyle drugs and body dysmorphic disorder: Overview on a new phenomenon in dermatology
a a a |
Author keywords
Body dysmorphic disorder; Lifestyle drugs
|
Indexed keywords
ANIRACETAM;
BENZODIAZEPINE DERIVATIVE;
BOTULINUM TOXIN;
BROMOCRIPTINE MESILATE;
CLOMIPRAMINE;
CYPRODENATE;
DEANOL;
DESIPRAMINE;
DEXFENFLURAMINE;
DIHYDROERGOTOXINE MESILATE;
FINASTERIDE;
FLUOXETINE;
FLUVOXAMINE;
IDEBENONE;
KETAMINE;
LEVACECARNINE;
METHYLPHENIDATE;
NEUROLEPTIC AGENT;
OXIRACETAM;
PIRACETAM;
PRAMIRACETAM;
SELEGILINE;
SIBUTRAMINE;
SILDENAFIL;
TETRAHYDROLIPSTATIN;
TRICYCLIC ANTIDEPRESSANT AGENT;
UNINDEXED DRUG;
VINCAMINE;
VINPOCETINE;
YOHIMBINE;
BODY DYSMORPHIC DISORDER;
CLINICAL FEATURE;
CLINICAL TRIAL;
COLOR VISION DEFECT;
COMORBIDITY;
DISEASE CLASSIFICATION;
ERECTILE DYSFUNCTION;
FECES INCONTINENCE;
FLATULENCE;
HEADACHE;
HUMAN;
PAIN;
PIGMENT DISORDER;
PRESCRIPTION;
PRIORITY JOURNAL;
PSYCHOPHARMACOLOGY;
PSYCHOTHERAPY;
REVIEW;
SKIN DISEASE;
|
EID: 0036068997
PISSN: 14229196
EISSN: None
Source Type: Journal
DOI: 10.1159/000064495 Document Type: Review |
Times cited : (3)
|
References (40)
|